Plasma protein levels and hepatocellular carcinoma: a Mendelian randomization study with drug screening implications

Plasma protein levels and hepatocellular carcinoma: a Mendelian randomization study with drug screening implications

Abstract Background Hepatocellular carcinoma (HCC) remains a significant cause of cancer-related mortality, highlighting the need for novel therapeutic strategies. Identifying key proteins and potential therapeutic agents is critical for improving treatment outcomes. Methods We employed Mendelian ra...

Full description

Saved in:
Bibliographic Details
Main Authors: Longhui Xie, Dekun Song, Jianwei Lan, Pengpeng Liu, Shuang Qin, Yinkuan Ning, Quanyan Liu
Format: Article
Language:English
Published: Springer 2025-04-01
Series:Discover Oncology
Subjects:
Hepatocellular carcinoma
Mendelian randomization
T cells
ODC1
Belinostat
Single-cell analysis
Online Access:https://doi.org/10.1007/s12672-025-02307-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s12672-025-02307-7

Similar Items